Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
January 15, 2000
Synkinesis following diabetic third nerve palsy
D Barr, M Kupersmith, R Turbin, et al.
Surgical Neurology
|
January 1, 1984
Transvascular treatment of giant aneurysms of the cavernous carotid and vertebral arteries. Functional investigation and embolization
A Berenstein, J Ransohoff, M Kupersmith, et al.
JAMA
|
November 28, 1977
Treatment of Parkinson's disease with lergotrile mesylate
A Lieberman, E Estey, M Kupersmith, et al.
Ocular Immunology and Inflammation
|
July 25, 2012
Skin biopsies in the evaluation of atypical optic neuropathies
L Bielory, M Kupersmith, F Warren, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1980
Evaluation of Parkinson's disease
A Lieberman, M Dziatolowski, G Gopinathan, et al.
Neurology
|
March 1, 1979
Bromocriptine in Parkinson disease: further studies
A N Lieberman, M Kupersmith, G Gopinathan, et al.
Neurology
|
February 1, 1979
Lergotrile in Parkinson disease: further studies
A N Lieberman, G Gopinathan, E Estey, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1980
Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's disease
D L Kleinberg, A Lieberman, J Todd, et al.
Ophthalmology
|
September 1, 1983
The pattern electroretinogram in optic nerve disease
W Seiple, M J Price, M Kupersmith, et al.
Annals of Neurology
|
October 1, 1979
Dementia in Parkinson Disease
A Lieberman, M Dziatolowski, M Kupersmith, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
January 15, 2000
Synkinesis following diabetic third nerve palsy
D Barr, M Kupersmith, R Turbin, et al.
Surgical Neurology
|
January 1, 1984
Transvascular treatment of giant aneurysms of the cavernous carotid and vertebral arteries. Functional investigation and embolization
A Berenstein, J Ransohoff, M Kupersmith, et al.
JAMA
|
November 28, 1977
Treatment of Parkinson's disease with lergotrile mesylate
A Lieberman, E Estey, M Kupersmith, et al.
Ocular Immunology and Inflammation
|
July 25, 2012
Skin biopsies in the evaluation of atypical optic neuropathies
L Bielory, M Kupersmith, F Warren, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1980
Evaluation of Parkinson's disease
A Lieberman, M Dziatolowski, G Gopinathan, et al.
Neurology
|
March 1, 1979
Bromocriptine in Parkinson disease: further studies
A N Lieberman, M Kupersmith, G Gopinathan, et al.
Neurology
|
February 1, 1979
Lergotrile in Parkinson disease: further studies
A N Lieberman, G Gopinathan, E Estey, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 1, 1980
Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's disease
D L Kleinberg, A Lieberman, J Todd, et al.
Ophthalmology
|
September 1, 1983
The pattern electroretinogram in optic nerve disease
W Seiple, M J Price, M Kupersmith, et al.
Annals of Neurology
|
October 1, 1979
Dementia in Parkinson Disease
A Lieberman, M Dziatolowski, M Kupersmith, et al.
Page
of 4